Head and Neck Squamous Cell Carcinoma Market - Top Companies and Manufacturers

Companies Dominating the Head and Neck Squamous Cell Carcinoma (HNSCC) Landscape

Immutep Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Novartis AG
Fortress Biotech, Inc.
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Bristol Myers Squibb Company
AstraZeneca PLC
Pfizer Inc.
Boehringer Ingelheim International GmbH
Checkpoint Therapeutics, Inc.

Browse Key Market Insights with Data Illustration:

Head and Neck Squamous Cell Carcinoma (HNSCC) Market Size & Share, Growth Trends 2037

In the News

Immutep Limited announced that it has completed the recruitment of patients having head and neck cancer and has safely dosed them for stage 2 of Part C of its Two ACTive Immunotherapies (TACTI-002) Phase II study trials.
Checkpoint Therapeutics, Inc. announced that it has expanded its partnership with Samsung Biologics Co., Ltd. for manufacturing the anti-PD-L1 antibody, cosibelimab on a commercial scale.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of head and neck squamous cell carcinoma is evaluated at USD 2.54 billion.

The head and neck squamous cell carcinoma market size was valued at USD 2.37 billion in 2024 and is likely to exceed USD 7.08 billion by the end of 2037, expanding at over 8.7% CAGR during the forecast period i.e., between 2025-2037. Growing R&D and approvals for cancer drugs and treatment, escalating consumption of alcohol, and growing adoption of immune therapeutics will boost the market growth.

North America is poised to dominate majority industry share of about 52% by 2037, propelled by increasing frequency of head and neck cancer driven by surging ratio of alcohol, and tobacco consumption in people in the region.

The major players in the market include Immutep Limited, Novartis AG, Fortress Biotech, Inc., F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca PLC, Pfizer Inc., Boehringer Ingelheim International GmbH, Checkpoint Therapeutics, Inc.

Head and Neck Squamous Cell Carcinoma Market - Top Companies and Manufacturers

Companies Dominating the Head and Neck Squamous Cell Carcinoma (HNSCC) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the head and neck squamous cell carcinoma market?

What are the factors driving the head and neck squamous cell carcinoma landscape?

Which region held the largest head and neck squamous cell carcinoma industry share?

Who are the key players in the head and neck squamous cell carcinoma sector?